|
|||||
|
|
Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice |
|
| Affiliation: | 1. Inserm U669, Maison des Adolescents, Hôpital Cochin, AP–HP, 75679 Paris France;2. Université Paris Descartes, 75006 Paris, France;3. Department of Cardiology, Hôpital Cochin, AP–HP, 75014 Paris, France;4. FA-7334 Internal Medicine, Hôpital Louis-Mourier, Université Paris 7, AP–HP, 92700 Colombes, France;5. Geriatrics Department, Hôpital Broca, AP–HP, 75013 Paris, France;6. Normandie Université, UNICAEN, Inserm U1237, CHU Caen, 14000 Caen, France;7. Department of Cardiology, Hôpital Européen Georges-Pompidou, AP–HP, 75015 Paris, France;8. ICTA, 21121 Fontaine-lès-Dijon, France;9. Bristol-Myers Squibb, 92506 Rueil-Malmaison, France;10. Department of Cardiology, Hôpital Bichat, AP–HP, 75018 Paris, France;11. Inserm U1148, Université Paris Diderot, 75877 Paris, France |
| Abstract: | |
| Keywords: | Anticoagulation Atrial fibrillation Non-vitamin K antagonist oral anticoagulants Observational study Vitamin K antagonists Anticoagulation Fibrillation auriculaire Anticoagulants directs oraux Étude observationnelle Antivitamine K AF" },{" #name" :" keyword" ," $" :{" id" :" kw0060" }," $$" :[{" #name" :" text" ," _" :" atrial fibrillation CI" },{" #name" :" keyword" ," $" :{" id" :" kw0070" }," $$" :[{" #name" :" text" ," _" :" confidence interval NOAC" },{" #name" :" keyword" ," $" :{" id" :" kw0080" }," $$" :[{" #name" :" text" ," _" :" non-vitamin K antagonist oral anticoagulant NVAF" },{" #name" :" keyword" ," $" :{" id" :" kw0090" }," $$" :[{" #name" :" text" ," _" :" non-valvular atrial fibrillation SmPC" },{" #name" :" keyword" ," $" :{" id" :" kw0100" }," $$" :[{" #name" :" text" ," _" :" summary of product characteristics VKA" },{" #name" :" keyword" ," $" :{" id" :" kw0110" }," $$" :[{" #name" :" text" ," _" :" vitamin K antagonist |
| 本文献已被 ScienceDirect 等数据库收录！ | |